Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological
Por um escritor misterioso
Descrição
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
Frontiers The Effects of Combined Therapy With Metformin and Hydroxypropyl -β-Cyclodextrin in a Mouse Model of Niemann-Pick Disease Type C1
Frontiers Pro-Inflammatory Implications of 2-Hydroxypropyl-β-cyclodextrin Treatment
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
IJMS, Free Full-Text
Cyclodextrin polymer improves atherosclerosis therapy and reduces ototoxicity - ScienceDirect
Synthesis and biological evaluation of novel β-cyclodextrin-fluvastatin conjugates - ScienceDirect
PDF) Intracerebroventricular 2-hydroxypropyl-β-cyclodextrin improves not only neurological symptoms but also hepatic abnormalities in Niemann-Pick disease type C model mice and patients
2-Hydroxypropyl-β-Cyclodextrin Raises Hearing Threshold in Normal Cats and in Cats With Niemann-Pick Type C Disease
Hydroxypropyl-Beta-Cyclodextrin Reduces Inflammatory Signaling from Monocytes: Possible Implications for Suppression of HIV Chronic Immune Activation
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
Differential mode of cholesterol inclusion with 2‐hydroxypropyl‐cyclodextrins increases safety margin in treatment of Niemann‐Pick disease type C - Yamada - 2021 - British Journal of Pharmacology - Wiley Online Library
Frontiers Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk
de
por adulto (o preço varia de acordo com o tamanho do grupo)
